Gilead Sciences Inc (GILD)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 8,329,000 8,384,000 10,119,000 9,096,000 8,499,000 8,260,000 8,474,000 8,838,000 6,694,000 5,367,000 6,372,000 6,589,000 9,918,000 11,629,000 9,788,000 4,559,000 4,071,000 2,513,000 -961,000 4,452,000
Revenue (ttm) US$ in thousands 28,749,000 28,295,000 27,800,000 27,450,000 27,116,000 27,390,000 27,382,000 27,043,000 27,281,000 27,136,000 27,515,000 27,472,000 27,305,000 27,482,000 26,638,000 25,564,000 24,689,000 23,147,000 22,174,000 22,716,000
Operating profit margin 28.97% 29.63% 36.40% 33.14% 31.34% 30.16% 30.95% 32.68% 24.54% 19.78% 23.16% 23.98% 36.32% 42.31% 36.74% 17.83% 16.49% 10.86% -4.33% 19.60%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $8,329,000K ÷ $28,749,000K
= 28.97%

The operating profit margin of Gilead Sciences Inc has shown variations over the quarters in the provided data period from March 31, 2020, to December 31, 2024.

The operating profit margin started at 19.60% in March 2020, indicating that for every dollar of revenue generated, the company had a profit of $0.1960 after covering all operating expenses.

The margin turned negative in June 2020, reaching -4.33%, suggesting that operating expenses exceeded operating income during that period, resulting in a loss. This could be due to factors such as increased expenses or a decline in revenue.

Subsequently, the operating profit margin improved, reaching double digits in September 2020 and December 2020 at 10.86% and 16.49%, respectively. This indicated better cost management and efficiency in generating operating income during these quarters.

The trend continued to improve in the following quarters, with the operating profit margin peaking at 42.31% in September 2021. This significant increase could be attributed to factors like increased revenue, cost control measures, or efficiency improvements in operations.

Moving forward, the operating profit margin remained relatively stable in the range of 23% to 36% through June 2024. This level of consistency indicates that the company is effectively managing its operating expenses relative to its operating income during this period.

In the most recent quarter, December 31, 2024, the operating profit margin decreased slightly to 28.97%. It is important for the company to monitor this trend to ensure that profitability is sustained over time.

Overall, the operating profit margin analysis highlights the company's ability to generate profit from its core operations, emphasizing the importance of maintaining a balance between revenue growth and cost management to sustain profitability in the long run.


See also:

Gilead Sciences Inc Operating Profit Margin (Quarterly Data)